Search Results - "SACKS, NAOMI C."

Refine Results
  1. 1

    Burden of illness and mortality in men with Adrenomyeloneuropathy: a retrospective cohort study by Bonkowsky, Joshua L, Healey, Bridget, Sacks, Naomi C, McLin, Ronaé, Cyr, Philip L, Sawyer, Eileen K, Stephen, Christopher D, Eichler, Florian

    Published in Orphanet journal of rare diseases (17-07-2024)
    “…Adrenomyeloneuropathy (AMN) is a neurodegenerative disease phenotype of X-linked adrenoleukodystrophy (ALD), resulting in progressive myeloneuropathy causing…”
    Get full text
    Journal Article
  2. 2

    Trends in acute myocardial infarction hospitalizations: Are we seeing the whole picture? by Sacks, Naomi C., PhD, Ash, Arlene S., PhD, Ghosh, Kaushik, PhD, Rosen, Amy K., PhD, Wong, John B., MD, Rosen, Allison B., MD, MPH, ScD

    Published in The American heart journal (01-12-2015)
    “…Background Payers and policy makers rely on studies of trends in acute myocardial infarction (AMI) hospitalizations and spending that count only…”
    Get full text
    Journal Article
  3. 3

    Disparities in the Management of Newly Diagnosed Paroxysmal Supraventricular Tachycardia for Women Versus Men in the United States by Sacks, Naomi C, Everson, Katie, Emden, Maia R, Cyr, Phillip L, Wood, David R, Raza, Sajjad, Wood, Kathryn A, Pokorney, Sean D

    Published in Journal of the American Heart Association (20-10-2020)
    “…Background Information on differences in paroxysmal supraventricular tachycardia (PSVT) diagnosis, healthcare resource use, expenditures, and treatment among…”
    Get full text
    Journal Article
  4. 4

    Comparison of claims data on hospitalization rates and repeat procedures in patients receiving a bowel preparation prior to colonoscopy by Young, Lisa E, Sacks, Naomi C, Cyr, Philip L, Sharma, Abhishek, Dahdal, David N

    Published in SAGE open medicine (01-01-2017)
    “…Objectives: To evaluate outcomes of colorectal screening using sodium picosulfate and magnesium citrate compared with other prescription bowel-preparation…”
    Get full text
    Journal Article
  5. 5

    Prevalence and incidence of patients with paroxysmal supraventricular tachycardia in the United States by Rehorn, Michael, Sacks, Naomi C., Emden, Maia R., Healey, Bridget, Preib, Madison T., Cyr, Philip L., Pokorney, Sean D.

    “…Background Paroxysmal supraventricular tachycardia (PSVT) encompasses a range of heart rhythm disorders leading to rapid heart rates. By virtue of its episodic…”
    Get full text
    Journal Article
  6. 6

    Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation by Sheshadri, Ajay, Sacks, Naomi C., Healey, Bridget E., Raza, Sajjad, Boerner, Gerhard, Huang, Howard J.

    Published in Clinical therapeutics (01-05-2022)
    “…Bronchiolitis obliterans syndrome (BOS) is a major cause of morbidity and mortality in lung transplantation and allogeneic hematopoietic stem cell…”
    Get full text
    Journal Article
  7. 7

    Catheter ablation for supraventricular tachycardia and health resource utilization and expenditures: A propensity-matched cohort study by Chew, Derek S., Sacks, Naomi C., Emden, Maia R., Cyr, Philip L., Sherwood, Rick, Pokorney, Sean D.

    Published in International journal of cardiology (15-05-2024)
    “…Few data are available regarding temporal patterns of health resource utilization (HRU) and expenditures among patients undergoing catheter ablation for…”
    Get full text
    Journal Article
  8. 8

    Trends in health care resource use and expenditures in patients with newly diagnosed paroxysmal supraventricular tachycardia in the United States by Chew, Derek S., Sacks, Naomi C., Emden, Maia R., Preib, Madison T., Cyr, Philip L., Wood, David, Pokorney, Sean D.

    Published in The American heart journal (01-03-2021)
    “…Few data are available on the temporal patterns of health resource utilization (HRU) and expenditures around paroxysmal supraventricular tachycardia (PSVT)…”
    Get full text
    Journal Article
  9. 9

    Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis by Feuerstadt, Paul, Boules, Mena, Stong, Laura, Dahdal, David N, Sacks, Naomi C, Lang, Kathleen, Nelson, Winnie W

    Published in SAGE open medicine (01-01-2021)
    “…Objective: Clostridioides difficile infection and recurrent C. difficile infection result in substantial economic burden and healthcare resource use. Sepsis…”
    Get full text
    Journal Article
  10. 10

    Healthcare Resource Use and Expenditures in Patients Newly Diagnosed With Paroxysmal Supraventricular Tachycardia by Sacks, Naomi C., Cyr, Philip L., Preib, Madison T., Everson, Katie, Wood, David R., Raza, Sajjad, Pokorney, Sean D.

    Published in The American journal of cardiology (15-01-2020)
    “…Information on paroxysmal supraventricular tachycardia (PSVT) patient characteristics and the associated economic burden of the disease is limited. Therefore,…”
    Get full text
    Journal Article
  11. 11

    Impact of Demographics and Insurance Coverage on Schizophrenia Treatment and Healthcare Resource Utilization Within an Integrated Healthcare System by Seo, Sanghyuk, Healey, Bridget E, McLin, Ronae, Sacks, Naomi C, Benson, Carmela J, Citrome, Leslie

    Published in Neuropsychiatric disease and treatment (30-09-2024)
    “…Little is known about the impact of health disparities on antipsychotic treatment and healthcare resource utilization (HRU) among patients with schizophrenia…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims by Sacks, Naomi C, Healey, Bridget E, Cyr, Philip L, Slocomb, Theodore, James, Emma, Beggs, Alan H, Graham, Robert J

    “…In X-linked myotubular myopathy (XLMTM), mutations in the gene result in absence or dysfunction of myotubularin, a protein required for normal development,…”
    Get full text
    Journal Article
  14. 14

    Burden of Acute Myeloid Leukemia Among Older, Newly Diagnosed Patients: Retrospective Analysis of Data From the 2010–2012 Medicare Limited Data Set by Sacks, Naomi C., Cyr, Philip L., Louie, Arthur C., Liu, Yanmei, Chiarella, Michael T., Sharma, Abhishek, Chung, Karen C.

    Published in Clinical therapeutics (01-05-2018)
    “…Acute myeloid leukemia (AML) disproportionately affects older adults; the prognosis in this subpopulation is generally poor, with variable use of inpatient…”
    Get full text
    Journal Article
  15. 15

    The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States by Sacks, Naomi C., Healey, Bridget E., Raza, Sajjad, Cyr, Philip L., Boerner, Gerhard, Sheshadri, Ajay

    Published in Blood advances (08-03-2022)
    “…Noninfectious pulmonary complications (NIPC) after allogeneic hematopoietic stem cell transplantation (alloHSCT), including bronchiolitis obliterans syndrome…”
    Get full text
    Journal Article
  16. 16

    Healthcare Utilization Among Infants Covered by Medicaid and Newly Diagnosed With Respiratory Syncytial Virus by Suh, Mina, Movva, Naimisha, Jiang, Xiaohui, Reichert, Heidi, Pastula, Susan T, Sacks, Naomi C, Frankenfeld, Cara, Fryzek, Jon P, Simões, Eric A F

    Published in Open forum infectious diseases (01-04-2024)
    “…Abstract Background Infants covered by Medicaid have higher respiratory syncytial virus (RSV) hospitalization rates than those with commercial insurance, but…”
    Get full text
    Journal Article
  17. 17

    Myopic and Forward Looking Behavior in Branded Oral Anti‐Diabetic Medication Consumption: An Example from Medicare Part D by Sacks, Naomi C., Burgess, James F., Cabral, Howard J., Pizer, Steven D.

    Published in Health economics (01-06-2017)
    “…Summary We evaluate consumption responses to the non‐linear Medicare Part D prescription drug benefit. We compare propensity‐matched older patients with…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia-Related Changes by Jensen, Ivar S, Wu, Elizabeth, Sacks, Naomi C, Cyr, Philip L, Chung, Karen C

    Published in American health & drug benefits (01-10-2018)
    “…Current national estimates for acute myelogenous leukemia (AML) indicate this disease accounts for 1.1% of new cancer diagnoses and 1.8% of cancer deaths in…”
    Get full text
    Journal Article
  20. 20

    Cost Sharing and Decreased Branded Oral Anti-Diabetic Medication Adherence Among Elderly Part D Medicare Beneficiaries by Sacks, Naomi C., Burgess, James F., Cabral, Howard J., Pizer, Steven D., McDonnell, Marie E.

    “…ABSTRACT BACKGROUND Although the Medicare Part D coverage gap phase-out should reduce cost-related nonadherence (CRN) among seniors with diabetes, preferential…”
    Get full text
    Journal Article